Literature DB >> 23960559

Expression of human beta defensins (HBDs) 1, 2 and 3 in gingival crevicular fluid of patients affected by localized aggressive periodontitis.

Mohamed Abdelmoniem Ebrahem1.   

Abstract

AIM: To study the effect of nonsurgical periodontal therapy on the expression frequencies of human beta-defensin (HBD)-1, -2, and -3 in the gingival crevicular fluid (GCF) of patients affected by localized aggressive periodontitis.
MATERIALS AND METHODS: Twenty patients affected by localized aggressive periodontitis (age range, 20-35 years) and 20 healthy subjects (age range, 21-37 years) were examined with clinical periodontal parameters and radiographic examination with the long-cone parallel technique. All periodontitis patients underwent nonsurgical periodontal therapy combined with doxycycline treatment and a maintenance program (including brushing with regular toothpaste). GCF samples were collected from patients and healthy control subjects at baseline as well as 3 months after periodontal therapy for the patient group.
RESULTS: In the patient group, the expression frequencies of HBD-1, -2, and -3 mRNA at baseline were 30%, 85%, and 35%, respectively, which changed after periodontal therapy to 80%, 45%, and 85%, respectively (all P < 0.001). In the healthy control subjects, the expression frequencies were 95%, 40%, and 95% for HBD-1, -2, and -3, respectively, which were different from those of diseased patients at baseline (all P < 0.001).
CONCLUSIONS: The appropriate expression of HBD peptides in health and disease may contribute to the maintenance of periodontal homeostasis, possibly through its antimicrobial effects and the promotion of adaptive immune responses.

Entities:  

Keywords:  Aggressive periodontitis; Beta defensins; PCR

Year:  2013        PMID: 23960559      PMCID: PMC3723143          DOI: 10.1016/j.sdentj.2013.02.004

Source DB:  PubMed          Journal:  Saudi Dent J        ISSN: 1013-9052


  28 in total

Review 1.  The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system.

Authors:  N Romani; G Schuler
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Defensins: antimicrobial peptides of innate immunity.

Authors:  Tomas Ganz
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

3.  Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract.

Authors:  A J Quayle; E M Porter; A A Nussbaum; Y M Wang; C Brabec; K P Yip; S C Mok
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  Granulocyte elastase activity and PGE2 levels in gingival crevicular fluid in relation to the presence of subgingival periodontopathogens in subjects with untreated adult periodontitis.

Authors:  L J Jin; P O Söder; W K Leung; E F Corbet; L P Samaranayake; B Söder; W I Davies
Journal:  J Clin Periodontol       Date:  1999-08       Impact factor: 8.728

5.  Localization of human intestinal defensin 5 in Paneth cell granules.

Authors:  E M Porter; L Liu; A Oren; P A Anton; T Ganz
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.

Authors:  J Harder; J Bartels; E Christophers; J M Schroder
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

7.  Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction.

Authors:  J R García; F Jaumann; S Schulz; A Krause; J Rodríguez-Jiménez; U Forssmann; K Adermann; E Klüver; C Vogelmeier; D Becker; R Hedrich; W G Forssmann; R Bals
Journal:  Cell Tissue Res       Date:  2001-11       Impact factor: 5.249

8.  Expression of human beta-defensins-1 and -2 peptides in unresolved chronic periodontitis.

Authors:  Qian Lu; Lijian Jin; Richard P Darveau; Lakshman P Samaranayake
Journal:  J Periodontal Res       Date:  2004-08       Impact factor: 4.419

9.  Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel.

Authors:  D E Jones; C L Bevins
Journal:  FEBS Lett       Date:  1993-01-04       Impact factor: 4.124

10.  Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes.

Authors:  T Ganz
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

View more
  4 in total

1.  Study of the ultrastructure of Enterococcus faecalis and Streptococcus mutans incubated with salivary antimicrobial peptides.

Authors:  Blanca Blancas; María de Lourdes Lanzagorta; Luis Felipe Jiménez-Garcia; Reyna Lara; José Luis Molinari; Ana María Fernández
Journal:  Clin Exp Dent Res       Date:  2021-05-05

2.  Effect of Sudarshan Kriya Pranayama on periodontal status and human salivary beta-defensin-2: An interventional study.

Authors:  R Ananthalakshmi; Jaideep Mahendra; P Jayamathi; Little Mahendra; Nashra Kareem; S Subramaniam
Journal:  Dent Res J (Isfahan)       Date:  2018 Sep-Oct

3.  Human β-defensin 3 gene modification promotes the osteogenic differentiation of human periodontal ligament cells and bone repair in periodontitis.

Authors:  Lingjun Li; Han Jiang; Rixin Chen; Jing Zhou; Yin Xiao; Yangheng Zhang; Fuhua Yan
Journal:  Int J Oral Sci       Date:  2020-04-29       Impact factor: 6.344

4.  Expression and antimicrobial character of cells transfected with human β‑defensin‑3 against periodontitis‑associated microbiota in vitro.

Authors:  Minwen Zhu; Bo Miao; Jianhua Zhu; Haiyan Wang; Zengtong Zhou
Journal:  Mol Med Rep       Date:  2017-07-04       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.